"General Hospital" actress Haley Pullos appeared in Los Angeles court this week for her latest hearing related to her DUI arrest in April.

The 25-year-old wore a short blue-green dress with transparent sleeves and white heels as she walked outside the LA-area courthouse Wednesday. A brace, presumably from the injuries she suffered in her April crash, was visible on her right ankle. 

In court, Judge Terry Smerling ruled the case would be continued until October, a lawyer for the victim confirmed to Fox News Digital. 

The actress has been charged with felony DUI from an April 29 crash. She was allegedly driving the wrong way on State Route 134 in Pasadena around 1:30 a.m. before crashing her vehicle into another car. 

DICK VAN DYKE INVOLVED IN SINGLE-CAR ACCIDENT IN CALIFORNIA 

The Pasadena City Fire Department used the Jaws of Life to free Pullos from her car, the California Highway Patrol told Fox News Digital at the time.

Pullos reportedly used crutches in her court appearance in July. 

CLICK HERE TO SIGN UP FOR OUR ENTERTAINMENT NEWSLETTER

She is also being sued by Courtney Wilder, 23, the driver whose car Pullos allegedly smashed into.

Pullos was accused of "dangerously and recklessly" driving while "drunk and intoxicated on marijuana," court documents say.

The head-on collision with Wilder caused "severe damage and lasting injuries," the documents said. 

Pullos has reportedly pleaded not guilty to all the charges, according to the Los Angeles Times. 

CLICK HERE TO GET THE FOX NEWS APP

Pullos has played character Molly Lansing-Davis on "General Hospital" since she was a child. The role has been temporarily recast. 

Fox News Digital has reached out to reps for Pullos for comment. 

The U.S. Department of Health and Human Services has delivered a recommendation to the Drug Enforcement Administration on marijuana policy, and Senate leaders hailed it Wednesday as a first step toward easing federal restrictions on the drug.

HHS Secretary Xavier Becerra said Wednesday on X, the platform formerly known as Twitter, that the agency has responded to President Joe Biden's request "to provide a scheduling recommendation for marijuana to the DEA."

"We’ve worked to ensure that a scientific evaluation be completed and shared expeditiously," he added.

Senate Majority Leader Chuck Schumer said in a statement that HHS had recommended that marijuana be moved from a Schedule I to a Schedule III controlled substance.

"HHS has done the right thing," Schumer, D-N.Y., said. "DEA should now follow through on this important step to greatly reduce the harm caused by draconian marijuana laws."

LOOK WHO'S EXPERIMENTING WITH MARIJUANA TODAY MORE THAN ANY OTHER AGE GROUP

Rescheduling the drug would reduce or potentially eliminate criminal penalties for possession. Marijuana is currently classified as a Schedule I drug, alongside heroin and LSD.

According to the DEA, Schedule I drugs "have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse."

Schedule III drugs "have a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence." They currently include ketamine and some anabolic steroids.

Biden requested the review in October 2022 as he pardoned thousands of Americans convicted of "simple possession" of marijuana under federal law.

Senate Finance Committee Chairman Ron Wyden, D-Ore., issued a statement calling for marijuana to be completely descheduled. "However, the recommendation of HHS to reschedule cannabis as a Schedule III drug is not inconsequential," he added. "If HHS’s recommendation is ultimately implemented, it will be a historic step for a nation whose cannabis policies have been out of touch with reality."

Bloomberg News first reported on the HHS recommendation.

In reaction to the Bloomberg report, the nonprofit U.S. Cannabis Council said: "We enthusiastically welcome today’s news. ... Rescheduling will have a broad range of benefits, including signaling to the criminal justice system that cannabis is a lower priority and providing a crucial economic lifeline to the cannabis industry."